Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Medicare's Bridge program launched July 1 offering eligible beneficiaries Wegovy, Zepbound, and Foundayo at $50 per month out-of-pocket, with eligibility hinging on BMI thresholds, specific chronic condition combinations, and prior treatment histories.
- The Trump administration canceled the planned "Balance" phase — which would have integrated GLP-1 therapies into Medicare Part D — and extended Bridge through the end of 2027.
- Bridge participation requires extensive documentation, prior authorizations, appeals, and navigation of evolving coverage rules; the source says this administrative work can rival the clinical work itself for primary care physicians.
- Some private practices may decline Bridge participation or limit enrollment assistance due to staffing constraints, which the source warns could create a two-tier system where access depends on a practice's administrative capacity rather than medical need.
- Clinical pharmacists have been "invaluable" in helping physicians and patients navigate Bridge, but the source notes pharmacists are a costly resource with limited capacity that cannot absorb the workload at scale.
- Even before Bridge, GLP-1 prescribing for weight loss already required BMI verification, comorbidity assessment, prior weight-management documentation, insurer-specific paperwork, and shortage-driven treatment pivots, per the source.
- Jeffrey Millstein, an internist and regional medical director for primary and specialty care at Penn Medicine, authored the piece calling for simplified eligibility, reduced documentation, fewer prior authorizations, and drug price deflation.
Why it matters: The $50 headline price is a real affordability win, but the prior authorizations, documentation, and appeals required for each Bridge enrollment sit on top of primary care practices already facing workforce shortages and burnout — meaning patients who qualify on paper may still struggle to find a practice willing to shepherd them through, effectively recreating access barriers despite the discounted price.
Ask SkimNews
